|Long-term results of hypofractionated radiation therapy for breast cancer|
TJ Whelan, JP Pignol, MN Levine, JA Julian, R MacKenzie, S Parpia, ...
New England Journal of Medicine 362 (6), 513-520, 2010
|Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy|
IA Olivotto, TJ Whelan, S Parpia, DH Kim, T Berrang, PT Truong, I Kong, ...
Journal of Clinical Oncology 31 (32), 4038-4045, 2013
|PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma|
JR Perry, JA Julian, NJ Laperriere, W Geerts, G Agnelli, LR Rogers, ...
Journal of Thrombosis and Haemostasis 8 (9), 1959-1965, 2010
|d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant TherapyA Cohort Studyd-Dimer Testing to Select Patients With VTE …|
C Kearon, FA Spencer, D O'keeffe, S Parpia, S Schulman, T Baglin, ...
Annals of internal medicine 162 (1), 27-34, 2015
|Randomized trial of decongestive lymphatic therapy for the treatment of lymphedema in women with breast cancer|
IS Dayes, TJ Whelan, JA Julian, S Parpia, KI Pritchard, DP D'Souza, ...
Journal of Clinical Oncology 31 (30), 3758-3763, 2013
|Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized RatiosA Randomized Trial|
S Schulman, S Parpia, C Stewart, L Rudd-Scott, JA Julian, M Levine
Annals of internal medicine 155 (10), 653-659, 2011
|Selective d-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous ThrombosisA Randomized Trial|
LA Linkins, SM Bates, E Lang, SR Kahn, JD Douketis, J Julian, S Parpia, ...
Annals of internal medicine 158 (2), 93-100, 2013
|Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy|
AL Bane, TJ Whelan, GR Pond, S Parpia, G Gohla, AW Fyles, JP Pignol, ...
Annals of Oncology 25 (5), 992-998, 2014
|Predictors of Adverse Cosmetic Outcome in the RAPID Trial: An Exploratory Analysis|
D Peterson, PT Truong, S Parpia, IA Olivotto, T Berrang, DH Kim, I Kong, ...
International Journal of Radiation Oncology* Biology* Physics 91 (5), 968-976, 2015
|Improvement in the quality of abstracts in major clinical journals since CONSORT extension for abstracts: A systematic review|
L Mbuagbaw, M Thabane, T Vanniyasingam, VB Debono, S Kosa, ...
Contemporary clinical trials 38 (2), 245-250, 2014
|Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability|
C Kearon, K de Wit, S Parpia, S Schulman, M Afilalo, A Hirsch, ...
New England Journal of Medicine 381 (22), 2125-2134, 2019
|Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External-Beam Radiation Therapy with External-Beam Radiation Therapy Alone in Node-Negative Locally …|
IS Dayes, S Parpia, J Gilbert, JA Julian, IR Davis, MN Levine, J Sathya
International Journal of Radiation Oncology* Biology* Physics, 2017
|The prevalence and significance of a short QT interval in 18 825 low-risk individuals including athletes|
H Dhutia, A Malhotra, S Parpia, V Gabus, G Finocchiaro, G Mellor, ...
Br J Sports Med 50 (2), 124-129, 2016
|Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel|
S Vedantham, SR Kahn, SZ Goldhaber, AJ Comerota, S Parpia, S Meleth, ...
Vascular Medicine 21 (4), 400-407, 2016
|Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic …|
MJ Clemons, B Cochrane, GR Pond, N Califaretti, SKL Chia, RA Dent, ...
Breast cancer research and treatment 146 (1), 153-162, 2014
|Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism|
C Kearon, S Parpia, FA Spencer, T Baglin, SM Stevens, KA Bauer, ...
Blood 131 (19), 2151-2160, 2018
|Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism|
S Parpia, JA Julian, L Thabane, AYY Lee, FR Rickles, MN Levine
Contemporary clinical trials 32 (6), 829-833, 2011
|Rapid quantitative D‐dimer to exclude pulmonary embolism: a prospective cohort management study|
SM Bates, S Takach Lapner, JD Douketis, C Kearon, J Julian, S Parpia, ...
Journal of Thrombosis and Haemostasis 14 (3), 504-509, 2016
|Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non–Small-Cell Lung …|
A Swaminath, M Wierzbicki, S Parpia, JR Wright, TK Tsakiridis, ...
Clinical lung cancer 18 (2), 250-254, 2017
|Dalteparin Low Molecular Weight Heparin (LMWH) in ovarian cancer: A phase II randomized study|
LM Elit, AY Lee, S Parpia, LL Swystun, PC Liaw, P Hoskins, DH Julian, ...
Thrombosis research 130 (6), 894-900, 2012